{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:03:07Z","timestamp":1782907387813,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","award":["032018"],"award-info":[{"award-number":["032018"]}],"id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ajt.2022.11.005","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T08:55:49Z","timestamp":1673513749000},"page":"629-635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4613-8107","authenticated-orcid":false,"given":"Siobhan","family":"Sutcliffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-0369","authenticated-orcid":false,"given":"Mengmeng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-9556","authenticated-orcid":false,"given":"Su-Hsin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-4842","authenticated-orcid":false,"given":"Darren","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5684-0613","authenticated-orcid":false,"given":"David A.","family":"Axelrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9423-4849","authenticated-orcid":false,"given":"Krista L.","family":"Lentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Wellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-1180","authenticated-orcid":false,"given":"Louai","family":"Alrata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1919-1970","authenticated-orcid":false,"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-0817","authenticated-orcid":false,"given":"Tarek","family":"Alhamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajt.2022.11.005_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2215\/CJN.10960720","article-title":"Trends in discard of kidneys from hepatitis C viremic donors in the United States","volume":"16","author":"Chang","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ajt.2022.11.005_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/TP.0000000000001953","article-title":"Long-term patient and graft survival of kidney transplant recipients with hepatitis C virus infection in the United States","volume":"102","author":"Heo","year":"2018","journal-title":"Transplantation"},{"issue":"13","key":"10.1016\/j.ajt.2022.11.005_bib3","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199209243271302","article-title":"Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs","volume":"327","author":"Pereira","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ajt.2022.11.005_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"issue":"27","key":"10.1016\/j.ajt.2022.11.005_bib5","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ajt.2022.11.005_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jhep.2015.10.005","article-title":"Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir\/paritaprevir\/r and dasabuvir for 12 weeks","volume":"64","author":"Feld","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"27","key":"10.1016\/j.ajt.2022.11.005_bib7","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection","volume":"373","author":"Foster","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ajt.2022.11.005_bib8","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","volume":"67","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ajt.2022.11.005_bib9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/cid\/ciw496","article-title":"Ribavirin-free regimen with sofosbuvir and velpatasvir is associated with high efficacy and improvement of patient-reported outcomes in patients with genotypes 2 and 3 chronic hepatitis C: results from Astral-2 and -3 clinical trials","volume":"63","author":"Younossi","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ajt.2022.11.005_bib10","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation consensus conference on the use of hepatitis C viremic donors in solid organ transplantation","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2022.11.005_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13598","article-title":"Use of HCV Ab+\/Nat- donors in HCV na\u00efve renal transplant recipients to expand the kidney donor pool","volume":"33","author":"Dao","year":"2019","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2022.11.005_bib12","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/ajt.15031","article-title":"Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia","volume":"18","author":"De Vera","year":"2018","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2022.11.005_bib13","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0041-1345(00)01572-4","article-title":"Kidney transplantation from a donor who is HCV antibody positive and HCV-RNA negative","volume":"32","author":"Tokumoto","year":"2000","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.ajt.2022.11.005_bib14","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0041-1345(00)01565-7","article-title":"A\u00a0case of renal transplantation received from a living donor with second-generation anti-hepatitis C virus antibody positive into an anti-hepatitis C virus antibody negative recipient","volume":"32","author":"Watanabe","year":"2000","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.ajt.2022.11.005_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ekir.2016.09.058","article-title":"Transplantation of renal allografts from organ donors reactive for HCV antibodies to HCV-negative recipients: safety and clinical outcome","volume":"2","author":"Nowak","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"11","key":"10.1016\/j.ajt.2022.11.005_bib16","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/ajt.15496","article-title":"Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals","volume":"19","author":"La Hoz","year":"2019","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2022.11.005_bib17","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/ajt.14701","article-title":"Are we underestimating the quality of aviremic hepatitis C-positive kidneys? time to reconsider","volume":"18","author":"Sibulesky","year":"2018","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2022.11.005_bib18","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1111\/ajt.15544","article-title":"Three-year follow-up of aviremic hepatitis C-positive kidneys","volume":"19","author":"Kling","year":"2019","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2022.11.005_bib19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/tri.12954","article-title":"Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study","volume":"30","author":"Bhamidimarri","year":"2017","journal-title":"Transpl Int"},{"issue":"8","key":"10.1016\/j.ajt.2022.11.005_bib20","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1681\/ASN.2016010030","article-title":"Hepatitis C virus infection in chronic kidney disease","volume":"27","author":"Ladino","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.ajt.2022.11.005_bib21","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1681\/ASN.2017060673","article-title":"Transplantation of kidneys from HCV-positive donors: how to best use a scarce resource","volume":"28","author":"Roth","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ajt.2022.11.005_bib22","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/ajt.13620","article-title":"Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents","volume":"16","author":"Sawinski","year":"2016","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2022.11.005_bib23","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.kint.2021.06.034","article-title":"A\u00a0review of kidney transplantation from HCV-viremic donors into HCV-negative recipients","volume":"100","author":"Daloul","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ajt.2022.11.005_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cld.2022.01.012","article-title":"The use of hepatitis C virus-positive organs in hepatitis C virus-negative recipients","volume":"26","author":"Kuntzen","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.ajt.2022.11.005_bib25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/apt.16508","article-title":"Systematic review: hepatitis C viraemic allografts to hepatitis C-negative recipients in solid organ transplantation","volume":"54","author":"Raasikh","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.ajt.2022.11.005_bib26","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1681\/ASN.2019050462","article-title":"National trends in utilization and 1-year outcomes with transplantation of HCV-viremic kidneys","volume":"30","author":"Potluri","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ajt.2022.11.005_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1053\/j.ajkd.2020.10.017","article-title":"Transplantation of kidneys from hepatitis C virus-infected donors to hepatitis C virus-negative recipients: one-year kidney allograft outcomes","volume":"77","author":"Molnar","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"24","key":"10.1016\/j.ajt.2022.11.005_bib28","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ajt.2022.11.005_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ckj\/sfx048","article-title":"Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes","volume":"10","author":"Cohen","year":"2017","journal-title":"Clin Kidney J"},{"issue":"8","key":"10.1016\/j.ajt.2022.11.005_bib30","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/ajt.12777","article-title":"Big data in organ transplantation: registries and administrative claims","volume":"14","author":"Massie","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2022.11.005_bib31","unstructured":"Organ Procurement and Transplantation Network Data. Accessed April 28, 2022. https:\/\/optn.transplant.hrsa.gov\/data\/."},{"issue":"4 Pt 2","key":"10.1016\/j.ajt.2022.11.005_bib32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1600-6135.2005.00840.x","article-title":"Transplant data: sources, collection and research considerations, 2004","volume":"5","author":"Dickinson","year":"2005","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2022.11.005_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/TP.0b013e3181ac620b","article-title":"A\u00a0comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index","volume":"88","author":"Rao","year":"2009","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ajt.2022.11.005_bib34","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/ajt.16984","article-title":"Don't stop thinking about tomorrow: ascertainment bias in pre-post design transplant registry studies","volume":"22","author":"Motter","year":"2022","journal-title":"Am J Transplant"},{"issue":"19","key":"10.1016\/j.ajt.2022.11.005_bib35","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ajt.2022.11.005_bib36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.ajt.2022.11.005_bib37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/aje\/kwq439","article-title":"Doubly robust estimation of causal effects","volume":"173","author":"Funk","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.ajt.2022.11.005_bib38","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ekir.2022.05.027","article-title":"The independent effects of procurement biopsy findings on 10-year outcomes of extended criteria donor kidney transplants","volume":"7","author":"Stewart","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.ajt.2022.11.005_bib39","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/TP.0000000000002949","article-title":"Impact of donor hepatitis C virus on kidney transplant outcomes for hepatitis C-positive recipients in the direct-acting antiviral era: time to revise the kidney donor risk index?","volume":"104","author":"Cannon","year":"2020","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.ajt.2022.11.005_bib40","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/ajt.14895","article-title":"The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes","volume":"18","author":"Axelrod","year":"2018","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2022.11.005_bib41","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1600-6143.2010.03091.x","article-title":"Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients","volume":"10","author":"Kucirka","year":"2010","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2022.11.005_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.34067\/KID.0001012019","article-title":"Should my patient accept a kidney from a hepatitis C virus\u2013infected donor?","volume":"1","author":"Pagan","year":"2020","journal-title":"Kidney360"},{"issue":"4","key":"10.1016\/j.ajt.2022.11.005_bib43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMp1505074","article-title":"Transplanting hepatitis C-positive kidneys","volume":"373","author":"Reese","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ajt.2022.11.005_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000486516","article-title":"Effect of the opioid crisis on the donor pool for kidney transplantation: an analysis of national kidney deceased donor trends from 2010\u20132016","volume":"47","author":"Chute","year":"2018","journal-title":"Am J Nephrol"},{"issue":"10","key":"10.1016\/j.ajt.2022.11.005_bib45","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1111\/ajt.13971","article-title":"Improving organ utilization to help overcome the tragedies of the opioid epidemic","volume":"16","author":"Goldberg","year":"2016","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2022.11.005_bib46","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1600-6143.2004.00606.x","article-title":"The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients","volume":"4","author":"Abbott","year":"2004","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2022.11.005_bib47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/ajt.14577","article-title":"Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys","volume":"18","author":"Bowring","year":"2018","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2022.11.005_bib48","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1097\/TXD.0000000000001056","article-title":"Financial evaluation of kidney transplant with hepatitis C viremic donors to uninfected recipients","volume":"6","author":"Axelrod","year":"2020","journal-title":"Transplant Direct"},{"issue":"10","key":"10.1016\/j.ajt.2022.11.005_bib49","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/ajt.15054","article-title":"Cost-effectiveness of hepatitis C-positive donor kidney transplantation for hepatitis C-negative recipients with concomitant direct-acting antiviral therapy","volume":"18","author":"Gupta","year":"2018","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2022.11.005_bib50","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2019.11.005","article-title":"Cost-effectiveness of using kidneys from HCV-viremic donors for transplantation into HCV-uninfected recipients","volume":"75","author":"Eckman","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.ajt.2022.11.005_bib51","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.34067\/KID.0004592020","article-title":"Survey of clinician opinions on kidney transplantation from hepatitis C virus positive donors: identifying and overcoming barriers","volume":"1","author":"Lentine","year":"2020","journal-title":"Kidney360."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522247820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522247820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:34:44Z","timestamp":1778621684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522247820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1600613522247820"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2022.11.005","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}